Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
2013 · Advances in Therapy · 62 citations
https://doi.org/10.1007/s12325-013-0069-5
L
Lærke Kjær Tolstrup
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
368
Citations
10
h-index
11
i10-index
Lærke Kjær Tolstrup is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Cancer survivorship and care & Cancer Immunotherapy and Biomarkers & Palliative Care and End-of-Life Issues. The author has an h-index of 10, co-authored 38 publications.
ORCID: 0000-0001-9554-5385Papers by this author
worksImpact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial
2022 · Journal of Patient-Reported Outcomes · 29 citations
https://doi.org/10.1186/s41687-022-00414-5
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study
2021 · European Journal of Cancer · 24 citations
https://doi.org/10.1016/j.ejca.2021.08.026
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
2023 · Acta Oncologica · 19 citations
https://doi.org/10.1080/0284186x.2023.2165449
Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form
2018 · Health and Quality of Life Outcomes · 17 citations
https://doi.org/10.1186/s12955-018-0900-4
Patient and Caregiver Education to Support Self‐Efficacy and Self‐Management During Immunotherapy—An Integrative Review
2025 · Psycho-Oncology · 5 citations
https://doi.org/10.1002/pon.70100
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat